Long is the medical director of Melanoma Institute Australia (MIA), and chair of melanoma medical oncology and translational research at MIA and Royal North Shore Hospital, The University of Sydney.
March 27, 2025
Video
The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.
My Invisible Illness: Living With Brain Fog After Brain Tumor Surgery
New System May Help Keep High-Risk Cancer Patients Out of Hospital
Explaining What is Biology-Guided Radiation Therapy in Cancer Care
Grounded in Nature: Finding Strength While Living with Lynch Syndrome